Calvin Qian Pan (Calvin Q Pan, C Q Pan, Calvin Pan)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 44

Top Venues

Alimentary pharmacology & therapeutics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Journal of viral hepatitis

Hepatology international

NYU Langone Health, Tisch Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU Langone Health, Tisch Hospital Sep 01 2012

United States

Professor of Medicine :: Division of Gastroenterology and Hepatology, Department of Medicine

Icahn School of Medicine at Mount Sinai Jan 01 2010 - Aug 30 2012

United States

Associate Professor :: Department of Medicine

Icahn School of Medicine at Mount Sinai Jul 01 2004 - Dec 31 2009

United States

Assistant Professor of Medicine :: Department of Medicine

Publications

Calvin Qian Pan, James S Park
Revamping hepatitis C global eradication efforts: towards simplified and enhanced screening, prevention, and treatment. Translational gastroenterology and hepatology 9 (2024)
Calvin Qian Pan, Bo Zhu, Tingdan Ye, Erhei Dai
Novel Approach: Maternal TAF Prophylaxis to Prevent HBV Transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Calvin Qian Pan, Lin Zhu, Andy S Yu, Yuchan Zhao, Bo Zhu, Erhei Dai
Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Gong Feng, Calvin Qian Pan, Ming-Hua Zheng
Letter: Boosting non-invasive tests-Opportunities and challenges from resmetirom. Alimentary pharmacology & therapeutics (2024)
Gong Feng, Calvin Qian Pan, Ming-Hua Zheng
Letter: Boosting non-invasive tests-Opportunities and challenges from resmetirom. Alimentary pharmacology & therapeutics 60 (3) (2024)
Gong Feng, Calvin Qian Pan, Ming-Hua Zheng
Letter: Boosting non-invasive tests-Opportunities and challenges from resmetirom. Alimentary pharmacology & therapeutics 60 (3) (2024)
Gong Feng, Calvin Qian Pan, Ming-Hua Zheng
Letter: Boosting non-invasive tests-Opportunities and challenges from resmetirom. Alimentary pharmacology & therapeutics 60 (3) (2024)
Calvin Qian Pan, James S Park
Revamping hepatitis C global eradication efforts: towards simplified and enhanced screening, prevention, and treatment. Translational gastroenterology and hepatology 9 (2024)
Scott K Fung, Calvin Qian Pan, Grace Lai-Hung Wong, Wai Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L Hann, Maciej S Jablkowski, Yun Joon Kim, Cihan Yurdaydin, Cheng-Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F Flaherty, Leland J Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young Suk Lim, Maria Buti Ferret
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary pharmacology & therapeutics (2023)
Shi Ouyang, Ziren Chen, Tingting Peng, Yawen Geng, Junchao Qiu, Zhirong Xiao, Calvin Qian Pan
Incidence and predictors of elevated postpartum alanine aminotransferase in chronic hepatitis B mothers: a prospective study protocol. BMC gastroenterology 23 (1) (2023)
Calvin Qian Pan
The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B. Antiviral therapy 27 (2) (2022)
Calvin Qian Pan, Nezam H Afdhal, Victor Ankoma-Sey, Ho Bae, Michael P Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie-Won Hann, W Ray Kim, Paul Kwo, Scott Milligan, Myron J Tong, K Rajender Reddy
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide. Hepatology communications 6 (8) (2022)
Calvin Qian Pan, Ira M Jacobson, Paul Martin, Paul Yien Kwo, Joseph Lim, Steven-Huy B Han, Ke-Qin Hu, Joseph Ahn, Myron J Tong
Letter to the editor: Both universal screening and vaccination are essential components of a multipronged approach to hepatitis B elimination. Hepatology (Baltimore, Md.) 75 (6) (2022)
Jonathan Li, Vivian Wu, Calvin Qian Pan
Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review. Hepatology international 16 (5) (2022)
Wenyan Zhang, Jing Zhang, Shan Tang, Yali Liu, Xiaofei Du, Lixia Qiu, Menglu Liu, Haibin Yu, Calvin Qian Pan
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis. Journal of clinical and translational hepatology 11 (1) (2022)
Xiu Sun, Calvin Qian Pan, Hui-Chun Xing
Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. Hepatology international 15 (5) (2021)
Bryan Chen, Harry Huang, Calvin Qian Pan
The role of gut microbiota in hepatitis B disease progression and treatment. Journal of viral hepatitis (2021)
Weihua Cao, Ming-Hui Li, Lu Zhang, Yao Lu, Shuling Wu, Ge Shen, Min Chang, Ruyu Liu, Yuanjiao Gao, Hongxiao Hao, Leiping Hu, Wei Yi, Calvin Qian Pan, Yao Xie
The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy. BioMed research international 2021 (2021)
Qi Wang, Wen Xie, Ligai Liu, Peng Peng, Calvin Qian Pan
Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease. Medicine 100 (18) (2021)
Wen Xie, Zhihai Chen, Qi Wang, Meihua Song, Ying Cao, Lin Wang, Calvin Qian Pan
Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study. Journal of medical virology 93 (5) (2021)
Calvin Qian Pan, Ting-Tsung Chang, Si Hyun Bae, Maurizia Brunetto, Wai-Kay Seto, Carla S Coffin, Susanna K Tan, Shuyuan Mo, John F Flaherty, Anuj Gaggar, Mindie H Nguyen, Mustafa Kemal Çelen, Alexander Thompson, Edward J Gane
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. PloS one 16 (5) (2021)
Calvin Qian Pan, Ming-Hui Li, Wei Yi, Lu Zhang, Yao Lu, Hong-Xiao Hao, Gang Wan, Wei-Hua Cao, Xing-Yue Wang, Chong-Ping Ran, Ge Shen, Shu-Ling Wu, Min Chang, Yuan-Jiao Gao, Yao Xie
Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens. Liver international : official journal of the International Association for the Study of the Liver 41 (7) (2021)
Calvin Qian Pan
The Role of Earlier Use of Immunoprophylaxis in Preventing Mother-to-Child Transmission of Hepatitis B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (1) (2021)
Calvin Qian Pan, Erhei Dai, Zhongping Duan, Guorong Han, Wenjing Zhao, Yuming Wang, Huaihong Zhang, Baoshen Zhu, Hongxiu Jiang, Shuqin Zhang, Xiaohu Zhang, Huaibin Zou, Xiuli Chen, Yu Chen
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China. Gut (2021)
Calvin Qian Pan, Lihua Cao, Yan Huang
Editorial: tenofovir alafenamide fumarate-a new bullet to prevent mother-to-child transmission of hepatitis B virus. Authors' reply. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Calvin Qian Pan, Charles Rabinovich, Vijay Gayam, Milana Normatov, Bazhena Fidman, Dan Wang
Late presenters among minority patients with chronic hepatitis C infection in the USA. International journal of public health 65 (7) (2020)
Xin Chi, Calvin Qian Pan, Shunai Liu, Danying Cheng, Ziwen Cao, Hui-Chun Xing
Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Canadian journal of gastroenterology & hepatology 2020 (2020)
Song Yang, Min Quan, Yue Li, Calvin Qian Pan, Huichun Xing
Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty's Syndrome: A Case Report and Literature Review. BioMed research international 2020 (2020)
James S Park, Vijay Gayam, Calvin Qian Pan
Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals. Alimentary pharmacology & therapeutics 52 (6) (2020)
Li-Xin Xiao, Yi-Ru Chen, Ping Huang, Yong-Yu Mei, Calvin Qian Pan, Chao-Shuang Lin
The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy. Journal of medical virology (2020)
Calvin Qian Pan, Hua Zhang
Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Authors' reply. Alimentary pharmacology & therapeutics 50 (4) (2020)
Qing Liu, Ming Wang, Vijay Gayam, Xiu-Lan Li, Fu-Chuan Wang, Calvin Qian Pan
The clinical course and management of cervical cancer with splenic metastasis: Case report and review of the literature. Clinical case reports 9 (2) (2020)
Yang Ding, Lihua Cao, Liying Zhu, Yan Huang, Chaoshuang Lin, Yuming Wang, Yingxia Liu, Qiuju Sheng, Shouyun Wang, Jian Fan, Ruochan Chen, Weiqiang Gan, Bryan Chen, Calvin Qian Pan
Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. Alimentary pharmacology & therapeutics 52 (8) (2020)
Min-Ran Li, Zun-Gui Xu, Jian-Hua Lu, Huan-Wei Zheng, Li-Hong Ye, Yun-Yan Liu, Zhi-Quan Liu, Hai-Cong Zhang, Yan Huang, Er-Hei Dai, Calvin Qian Pan
Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of viral hepatitis 27 (10) (2020)
Janice Lyu, Su Wang, Qingqing He, Calvin Qian Pan, Amy S Tang
Hep B Moms: A cross-sectional study of mother-to-child transmission risk among pregnant Asian American women with chronic hepatitis B in New York City, 2007-2017. Journal of viral hepatitis 27 (2) (2019)
M J Tong, Calvin Qian Pan
Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans-Authors' reply. Alimentary pharmacology & therapeutics 47 (11) (2019)
Calvin Qian Pan
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Author's reply. Alimentary pharmacology & therapeutics 49 (6) (2019)
Calvin Qian Pan, Vijay Gayam, Charles Rabinovich, Milana Normatov, Bazhena Fidman, Dan Wang, Pavani Garlapati
Efficacy of Direct-Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United States. Journal of the American Geriatrics Society 68 (2) (2019)
Ming Wang, Qian Bian, Yunxia Zhu, Qiumei Pang, Lingzhi Chang, Ran Li, Benjamin C Tiongson, Hua Zhang, Calvin Qian Pan
Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Alimentary pharmacology & therapeutics 49 (2) (2018)
Wen Xie, Qi Wang, Yuanjiao Gao, Calvin Qian Pan
Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report. BMC gastroenterology 18 (1) (2018)
M J Tong, Calvin Qian Pan, S-H B Han, D S-K Lu, S Raman, Ke-Qin Hu, Joseph K Lim, H W Hann, A D Min
An expert consensus for the management of chronic hepatitis B in Asian Americans. Alimentary pharmacology & therapeutics 47 (8) (2018)
Andrea L Cathcart, Henry Lik-Yuen Chan, Neeru Bhardwaj, Yang Liu, Patrick Marcellin, Calvin Qian Pan, null Shalimar, Maria Buti, Stephanie Cox, Bandita Parhy, Eric Zhou, Ross Martin, Silvia Chang, Lanjia Lin, John F Flaherty, Kathryn M Kitrinos, Anuj Gaggar, Namiki Izumi, Young-Suk Lim
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrobial agents and chemotherapy 62 (10) (2018)
Song Yang, Huichun Xing, Shenghu Feng, Wei Ju, Shunai Liu, Xiaomei Wang, Weini Ou, Jun Cheng, Calvin Qian Pan
Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C. Archives of virology 163 (2) (2017)
Joel Lavinsky, Marshall Ge, Amanda L Crow, Calvin Qian Pan, Juemei Wang, Pezhman Salehi, Anthony Myint, Eleazar Eskin, Hooman Allayee, Aldons J Lusis, Robert C Rennert
The Genetic Architecture of Noise-Induced Hearing Loss: Evidence for a Gene-by-Environment Interaction. G3 (Bethesda, Md.) 6 (10) (2016)

Calvin Qian Pan.css-eqlu8i{font-size:small;padding-left:4px;} (Calvin Q Pan, C Q Pan, Calvin Pan)

Publication Activity (10 Years)

Top Topics

Top Venues

Calvin Qian Pan (Calvin Q Pan, C Q Pan, Calvin Pan)